Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Experimental and Applied Biomedical Research (EABR)
Volume 20 (2019): Issue 3 (September 2019)
Open Access
Synergism of PDL/PD1 and IL33/ST2 Axis in Tumor Immunology
Marina Jovanovic
Marina Jovanovic
,
Nevena Gajovic
Nevena Gajovic
,
Miodrag L. Lukic
Miodrag L. Lukic
,
Ana Popovic
Ana Popovic
and
Ivan Jovanovic
Ivan Jovanovic
| Nov 07, 2019
Experimental and Applied Biomedical Research (EABR)
Volume 20 (2019): Issue 3 (September 2019)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Nov 07, 2019
Page range:
223 - 228
Received:
Aug 31, 2018
Accepted:
Sep 04, 2018
DOI:
https://doi.org/10.2478/sjecr-2018-0033
Keywords
IL-33
,
PD-1
,
tumor
,
antitumor immunity
© 2019 Marina Jovanovic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Marina Jovanovic
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac
Serbia
Nevena Gajovic
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac
Serbia
Miodrag L. Lukic
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac
Serbia
Ana Popovic
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac
Serbia
Ivan Jovanovic
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac
Serbia